References
1. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children.New England Journal of Medicine 2015; 373 (16): 1541-52.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA: A
Cancer Journal for Clinicians 2017; 67 (1): 7-30.
3. Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among
survivors of childhood acute lymphoblastic leukemia: a report from the
Childhood Cancer Survivor Study. Blood 2008; 111 (12):
5515-23.
4. Yetgin S, Olgar Ş, Aras T, et al. Evaluation of kidney damage in
patients with acute lymphoblastic leukemia in long-term follow-up: Value
of renal scan. American Journal of Hematology 2004;77 (2): 132-
5. Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL. Obesity and
hypertension among children after treatment for acute lymphoblastic
leukemia. Cancer 2007; 110 (10): 2313-20.
6. Krawczuk-Rybak MM. Renal function during and after treatment for
acute lymphoblastic leukemia in children. Pediatric nephrology
(Berlin, West) 2005; 20 (6): 782-5.
7. Hovi L. Risk of progressive kidney damage after acute leukemia.Acta pædiatrica Scandinavica 1989; 78 (4): 608-14.
8. Veringa SJE, van Dulmen-den Broeder E, Kaspers GJL, Veening MA. Blood
pressure and body composition in long-term survivors of childhood acute
lymphoblastic leukemia. Pediatric Blood & Cancer 2012;58 (2): 278-82.
9. Levy E, Samoilenko M, Morel S, et al. Cardiometabolic Risk Factors in
Childhood, Adolescent and Young Adult Survivors of Acute Lymphoblastic
Leukemia – A Petale Cohort. Scientific Reports 2017;7 (1): 17684.
10. Louis CUCU. High blood pressure and hypertension in children with
newly diagnosed acute leukemia and lymphoma. Pediatric nephrology
(Berlin, West) 2008; 23 (4): 603-9.
11. Attard-Montalto SPS. High incidence of hypertension in children
presenting with acute lymphoblastic leukemia. Pediatric hematology
and oncology 1994; 11 (5): 519-25.
12. Nottage KA, Ness KK, Li C, Srivastava D, Robison LL, Hudson MM.
Metabolic syndrome and cardiovascular risk among long-term survivors of
acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.British Journal of Haematology 2014; 165 (3): 364-74.
13. Saultier P, Auquier P, Bertrand Y, et al. Metabolic syndrome in
long-term survivors of childhood acute leukemia treated without
hematopoietic stem cell transplantation: an L.E.A. study.Haematologica 2016; 101 (12): 1603-10.
14. Oudin C, Simeoni M-C, Sirvent N, et al. Prevalence and risk factors
of the metabolic syndrome in adult survivors of childhood leukemia.Blood 2011; 117 (17): 4442-8.
15. Bakk I, O’Brien S, Reed S, Koch T. Steroid-Induced Hypertension
during Induction Chemotherapy for Acute Lymphoblastic Leukemia in US
Children’s Hospitals. Jour Pediatr Hematol Oncol. 2014;124 (21): 3651-.
16. Luciano RL, Brewster UC. Kidney Involvement in Leukemia and
Lymphoma. Advances in Chronic Kidney Disease 2014;21 (1): 27-35.
17. Bakris GLGL. Slowing nephropathy progression: focus on proteinuria
reduction. Clinical journal of the American Society of Nephrology2008; 3 Suppl 1 (supplement 1): S3-S10.
18. Oeffinger KC. Cardiovascular risk factors in young adult survivors
of childhood acute lymphoblastic leukemia. Journal of pediatric
hematology/oncology 2001; 23 (7): 424-30.
19. Talvensaari KK, Lanning M, Tapanainen P, Knip M. Long-term survivors
of childhood cancer have an increased risk of manifesting the metabolic
syndrome. The Journal of Clinical Endocrinology & Metabolism1996; 81 (8): 3051-5.
20. Olgar SS. Can renal leukemic infiltration cause hypertension in
children? Journal of pediatric hematology/oncology 2006;28 (9): 579-84.
21. Essig S, Li Q, Chen Y, et al. Risk of late effects of treatment in
children newly diagnosed with standard-risk acute lymphoblastic
leukaemia: a report from the Childhood Cancer Survivor Study cohort.The Lancet Oncology 2014; 15 (8): 841-51.
22. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice
Guideline for Screening and Management of High Blood Pressure in
Children and Adolescents. Pediatrics 2017.
23. Ociepa T, Bartnik M, Zielezinska K, Urasinski T. Prevalence and Risk
Factors for Arterial Hypertension Development in Childhood Acute
Lymphoblastic Leukemia Survivors. Journal of Pediatric
Hematology/Oncology 2019; 41 (3): 175-80.
24. Levey AS, Stevens LA. Estimating GFR using the CKD Epidemiology
Collaboration (CKD-EPI) creatinine equation: more accurate GFR
estimates, lower CKD prevalence estimates, and better risk predictions.Am J Kidney Dis 2010; 55 (4): 622-7.
25. Staples A, LeBlond R, Watkins S, Wong C, Brandt J. Validation of the
revised Schwartz estimating equation in a predominantly non-CKD
population. Pediatr Nephrol 2010; 25 (11): 2321-6.
26. Group KDIGOAKIW. KDIGO clinical practice guideline for acute kidney
injury. Kidney Int Suppl 2012; 2 (1): 1-138.
27. Inker LA, Astor BC, Fox CH, et al. KDOQI US Commentary on the 2012
KDIGO Clinical Practice Guideline for the Evaluation and Management of
CKD. American Journal of Kidney Diseases ; 63 (5): 713-35.
28. Hogg RJ, Furth S, Lemley KV, et al. National Kidney Foundation’s
Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines
for Chronic Kidney Disease in Children and Adolescents: Evaluation,
Classification, and Stratification. Pediatrics 2003;111 (6): 1416-21.
29. Altay S, Onat A, Özpamuk-Karadeniz F, Karadeniz Y, Kemaloğlu-Öz T,
Can G. Renal ”hyperfiltrators” are at elevated risk of death and chronic
diseases. BMC nephrology 2014; 15 : 160-.
30. Flynn JT, Daniels SR, Hayman LL, et al. Update: Ambulatory Blood
Pressure Monitoring in Children and Adolescents. A Scientific
Statement From the American Heart Association 2014; 63 (5):
1116-35.
31. Urbina E, Alpert B, Flynn J, et al. Ambulatory Blood Pressure
Monitoring in Children and Adolescents: Recommendations for Standard
Assessment. A Scientific Statement From the American Heart
Association Atherosclerosis, Hypertension, and Obesity in Youth
Committee of the Council on Cardiovascular Disease in the Young and the
Council for High Blood Pressure Research 2008; 52 (3): 433-51.
32. Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: A
clinical review. World J Crit Care Med 2015; 4 (2):
130-8.
33. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical
significance of hyperfiltration in diabetes. Diabetologia 2010;53 (10): 2093-104.
34. Magee GM, Bilous RW, Cardwell CR, Hunter SJ, Kee F, Fogarty DG. Is
hyperfiltration associated with the future risk of developing diabetic
nephropathy? A meta-analysis. Diabetologia 2009; 52 (4):
691.
35. Calderon-Margalit R, Pleniceanu O, Tzur D, et al. Childhood Cancer
and the Risk of ESKD. Journal of the American Society of
Nephrology 2020: ASN.2020071002.
36. Mogensen CE, Christensen CK. Predicting Diabetic Nephropathy in
Insulin-Dependent Patients. New England Journal of Medicine 1984;311 (2): 89-93.
37. Bakris GL. Slowing nephropathy progression: focus on proteinuria
reduction. Clinical journal of the American Society of Nephrology
: CJASN 2008; 3 Suppl 1 (Suppl 1): S3-S10.
38. Phillips RA, Sheinart KF, Godbold JH, Mahboob R, Tuhrim S. The
association of blunted nocturnal blood pressure dip and stroke in a
multiethnic population. Am J Hypertens 2000; 13 (12):
1250-5.
39. Fagard RH, Celis H, Thijs L, et al. Daytime and Nighttime Blood
Pressure as Predictors of Death and Cause-Specific Cardiovascular Events
in Hypertension. Hypertension 2008; 51 (1): 55-61.
40. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M.
Predictors of All-Cause Mortality in Clinical Ambulatory Monitoring.Hypertension 2007; 49 (6): 1235-41.
41. Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus
night ambulatory blood pressure: a cohort study. The Lancet 2007;370 (9594): 1219-29.
42. Kario K, Pickering Thomas G, Matsuo T, Hoshide S, Schwartz Joseph E,
Shimada K. Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls
in Older Hypertensives. Hypertension 2001; 38 (4): 852-7.
43. Chang JC, Xiao R, Meyers KE, et al. Nocturnal blood pressure dipping
as a marker of endothelial function and subclinical atherosclerosis in
pediatric-onset systemic lupus erythematosus. Arthritis Research
& Therapy 2020; 22 (1): 129.
44. Karavanaki K, Kazianis G, Konstantopoulos I, Tsouvalas E, Karayianni
C. Early signs of left ventricular dysfunction in adolescents with type
1 diabetes mellitus: the importance of impaired circadian modulation of
blood pressure and heart rate. J Endocrinol Invest 2008;31 (4): 289-96.
45. Lee SH, Kim JH, Kang MJ, Lee YA, Won Yang S, Shin CH. Implications
of nocturnal hypertension in children and adolescents with type 1
diabetes. Diabetes Care 2011; 34 (10): 2180-5.
46. Brandt JR, Jacobs A, Raissy HH, et al. Orthostatic proteinuria and
the spectrum of diurnal variability of urinary protein excretion in
healthy children. Pediatric Nephrology 2010; 25 (6):
1131-7.
47. Group CsO. Long-Term Follow-up Guidelines for Survivors of
Childhood, Adolescent and Young Adult Cancerns. Monrovia, CA.
48. van der Velde M, Halbesma N, de Charro FT, et al. Screening for
Albuminuria Identifies Individuals at Increased Renal Risk.Journal of the American Society of Nephrology 2009;20 (4): 852-62.
49. Hoelzer D. Chemotherapy-free Treatment — A New Era in Acute
Lymphoblastic Leukemia? New England Journal of Medicine 2020;383 (17): 1673-4.
50. Inaba H, Pui CH. Immunotherapy in pediatric acute lymphoblastic
leukemia. Cancer Metastasis Rev 2019; 38 (4): 595-610.